Skip to content

Dr. Gwen Nichols: Addressing funding gaps in blood cancer research
Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome
Pathways & Perspectives with William Wierda, MD, PhD
How to sequence mezigdomide-based therapy in myeloma?
FDA approves rituximab biosimilar for B-cell malignancies

Insider Reader Survey

Join SOHO

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

MPN News

Myeloproliferative Neoplasms Primary Myelofibrosis News

FDA grants zavabresib orphan drug designation in myelofibrosis

by SOHO Insider Editors
January 27, 2026
0 Comments

Myeloproliferative Neoplasms SOHO Insider Podcast

Advances in essential thrombocythemia with Drs. Kuykendall, Tremblay

by Leah Sherwood
January 15, 2026
0 Comments

Trending now ASH 2025 Myeloproliferative Neoplasms Primary Myelofibrosis

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

by SOHO Insider Editors
December 31, 2025
0 Comments

Leukemia Acute Lymphoblastic Leukemia Myeloproliferative Neoplasms News

Pathways & Perspectives with Gabriela Hobbs, MD

by SOHO Insider Editors
October 27, 2025
0 Comments

EHA 2025 Myeloproliferative Neoplasms Video Interviews

Novel therapy INCA in ET shows positive results in early-phase data

by Leah Sherwood
July 18, 2025
0 Comments

EHA 2025 Meetings / Conferences Myeloproliferative Neoplasms

Dr. Kuykendall from EHA 2025: ‘the research is as hot as the conference center’

by SOHO Insider Editors
June 13, 2025
0 Comments

Myeloproliferative Neoplasms SOHO Insider Podcast

Drs. Kuykendall and Hobbs on MPN care in 2025

by Leah Sherwood
June 2, 2025
0 Comments

Rio de Janeiro, Brazil - September 10, 2020: ANVISA, National Health Surveillance Agency, on smartphone screen. In Brazil, it exercises sanitary control over all products and services

Myeloproliferative Neoplasms Polycythemia Vera News

ANVISA approves ropeginterferon alfa-2b in adults with polycythemia vera

by SOHO Insider Editors
March 25, 2025
0 Comments

Myeloproliferative Neoplasms

Addition of ropeginterferon alfa-2b to standard PV care is cost effective

by SOHO Insider Editors
February 28, 2025
0 Comments

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Abstract submissions now open for SOHO 2025

by Leah Sherwood
February 14, 2025
0 Comments

1
2
3
4

Top Categories

Cellular Therapy

75

Leukemia

120

Lymphoma

137

Multiple Myeloma

116

Myelodysplastic Syndromes

44

Myeloproliferative Neoplasms

35

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

MPN News

FDA grants zavabresib orphan drug designation in myelofibrosis

Advances in essential thrombocythemia with Drs. Kuykendall, Tremblay

Pathways & Perspectives with Gabriela Hobbs, MD

Novel therapy INCA in ET shows positive results in early-phase data

Dr. Kuykendall from EHA 2025: ‘the research is as hot as the conference center’

Drs. Kuykendall and Hobbs on MPN care in 2025

ANVISA approves ropeginterferon alfa-2b in adults with polycythemia vera

Addition of ropeginterferon alfa-2b to standard PV care is cost effective

Abstract submissions now open for SOHO 2025

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Dr. Gwen Nichols: Addressing funding gaps in blood cancer research

Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome

Pathways & Perspectives with William Wierda, MD, PhD

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

MPN News

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms